Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Controlled clinical trials have shown that a six-dose regimen of artemether-lumefantrine (AL) therapy for uncomplicated Plasmodium falciparum malaria results in cure rates >95% with good tolerability. MATERIALS AND METHODS: A prospective study was carried out to document the adherence to and acceptability of AL administration. This was undertaken in the context of the ALIVE study, a prospective, community-based, observational study in a rural, malaria-endemic area of Tanzania. Following microscopic confirmation of P. falciparum infection, the first AL dose was taken under supervision, with the subsequent five doses taken unsupervised at home. Patients were randomized to receive a home-based assessment close to the scheduled time for one of the unsupervised doses, but were blinded to which follow-up visit they had been allocated. A structured questionnaire was administered by trained staff and AL consumption was confirmed by inspection of blister packs. RESULTS: A total of 552 patients were recruited of whom 352 (63.8%) were <13 years old. The randomization process allocated 112, 109, 110, 100 and 111 patients to a follow-up visit after doses 2, 3, 4, 5 and 6, respectively. For dose 2, 92.0% of patients (103/112) correctly took AL at 8 +/- 1 hours after dose 1. The remaining doses were taken within four hours of the correct time in 87-95% of cases. Nine patients (1.7%) missed one dose. Blister packs were available for inspection in 548 of cases (99.3%) and confirmed patient-reported data that the previous dose had been administered. Nearly all patients took AL with water (549/552 [99.5%]). Two patients (0.4%) took the drug with food. The dosing pictogram and clustering of tablets within the blister packs was considered helpful by 91.8% and 100.0% of patients, respectively. Overall, 87.1% of patients (481/552) found AL easier to take/administer than sulphadoxine-pyrimethamine (SP) and 87.7% (484/552) believed that AL was more effective than SP. DISCUSSION: Factors contributing to adherence were likely to be helpful packaging, pictorial dosing instructions and patients' conviction that AL is effective. CONCLUSION: Adherence to the dosing regimen and timing of AL administration was very good.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The economic and social burden of malaria
Sachs, J., & Malaney, P. (2002) · Nature · doi:10.1038/415680a · Cited by 2,248 · cited 1×
“Background Malaria is the leading cause of outpatient and inpatient admissions in most sub-Saharan African countries, including Tanzania, and continues to exert a high burden in terms of mortality [1-3], morbidity [1,4] and health expenditure [5,6].”
BackgroundCONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY
BREMAN, J. G., ALILIO, M. S., & MILLS, A. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.2_suppl.0700001 · Cited by 677 · cited 1×
“Background Malaria is the leading cause of outpatient and inpatient admissions in most sub-Saharan African countries, including Tanzania, and continues to exert a high burden in terms of mortality [1-3], morbidity [1,4] and health expenditure [5,6].”
BackgroundGarber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004) · Medical Care · doi:10.1097/01.mlr.0000129496.05898.02 · Cited by 519
Bell, D. J., Wootton, D., Mukaka, M., Montgomery, J., Kayange, N., Chimpeni, P., Hughes, D. A., Molyneux, M. E., Ward, S. A., Winstanley, P. A., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-204 · Cited by 76
Rahman, M. M., Dondorp, A. M., Day, N. P. J., Lindegardh, N., Imwong, M., Faiz, M. A., Bangali, A. M., Kamal, A. T. M. M., Karim, J., Kaewkungwal, J., et al. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.05.022 · Cited by 54 · cited 3×
“The proportion of patients taking all five unsupervised doses was consistent with other reports for ACT in general [24,25] and AL in particular [26-29].”
BackgroundResult
Cited by
Banek, K., Lalani, M., Staedke, S. G., & Chandramohan, D. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-7 · Cited by 125
Mobile Phone Text Messaging: Tool for Malaria Control in Africa
Zurovac, D., Talisuna, A. O., & Snow, R. W. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001176 · Cited by 135
Bruxvoort, K., Goodman, C., Kachur, S. P., & Schellenberg, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084555 · Cited by 135
“3%–100%) [15,22,33], except in studies where the research team enrolled patients at the time the drug was obtained and likely had a more significant research presence than in other studies (90% and 93%) [19,61].”
ResultLemma, H., Löfgren, C., & San Sebastian, M. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-349 · Cited by 54
“In the study from Zambia, the inter-dose timing (+/-4 h) was wide compared to this one (+/-2 h), thus increasing the number of probably adherent patients [2].”
BackgroundInfluentialCohen, J. L., Yavuz, E., Morris, A., Arkedis, J., & Sabot, O. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-83 · Cited by 45
“A substantial amount of research has been conducted on adherence to ACT obtained through the public sector with generally encouraging results [24,26,28,29,33,34] overall.”
BackgroundBruxvoort, K., Festo, C., Kalolella, A., Cairns, M., Lyaruu, P., Kenani, M., Kachur, S. P., Goodman, C., & Schellenberg, D. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0126 · Cited by 27
Intervention to Promote Patients' Adherence to Antimalarial Medication: A Systematic Review
Fuangchan, A., Dhippayom, T., & Kongkaew, C. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.12-0598 · Cited by 27
Bruxvoort, K., Kalolella, A., Cairns, M., Festo, C., Kenani, M., Lyaruu, P., Kachur, S. P., Schellenberg, D., & Goodman, C. (2015) · Malaria Journal · doi:10.1186/s12936-015-0602-x · Cited by 16
“Based on adherence previously reported among patients obtaining ACT at public health facilities in Tanzania, which ranged from 75 to 98% [32-34], adherence among patients attending public health facilities was expected to be 75%, with lower adherence among patients attending ADDOs (60%).”
BackgroundGerstl, S., Namagana, A., Palacios, L., Mweshi, F., Aprile, S., & Lima, A. (2015) · Malaria Journal · doi:10.1186/s12936-015-0933-7 · Cited by 11
Talisuna, A. O. (2014) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000217 · Cited by 10
Metadata
- Authors
- Kabanywanyi, A. M., Lengeler, C., Kasim, P., King'eng'ena, S., Schlienger, R., Mulure, N., & Genton, B.
- Venue
- Malaria Journal
- Published
- 2010-02-11
- Volume
- 9
- Issue
- 1
- Pages
- 48-48
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2144453249
- Cited by
- 54
- References
- 5
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.